Nasal Glucagon: Potentially Viable Alternative to Treat Insulin-Induced Hypoglycemia in Adults with Type 1 Diabetes

Volume: 42, Issue: 5, Pages: S53 - S53
Published: Oct 1, 2018
Abstract
Commercially available glucagon requires reconstitution and injection, while investigational nasal glucagon (NG) is nasally administered (dry-powder spray formulation; single-use, ready-to-use device). This randomized, 2-period crossover study was conducted to demonstrate non-inferiority between intramuscular glucagon (IMG) and NG after insulin-induced hypoglycemia...
Paper Details
Title
Nasal Glucagon: Potentially Viable Alternative to Treat Insulin-Induced Hypoglycemia in Adults with Type 1 Diabetes
Published Date
Oct 1, 2018
Volume
42
Issue
5
Pages
S53 - S53
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.